{"id":258484,"date":"2026-08-23T05:08:33","date_gmt":"2026-08-23T05:08:33","guid":{"rendered":"https:\/\/www.europesays.com\/ee\/258484\/"},"modified":"2026-08-23T05:08:33","modified_gmt":"2026-08-23T05:08:33","slug":"elupaastev-sust-%e2%9f%a9-uudne-vaktsiin-ei-lase-agressiivsel-vahil-edasi-levida","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/ee\/258484\/","title":{"rendered":"ELUP\u00c4\u00c4STEV S\u00dcST \u27e9 Uudne vaktsiin ei lase agressiivsel v\u00e4hil edasi levida"},"content":{"rendered":"<p>Meditsiin on astumas uude ajastusse, kus v\u00e4hiravi ei ole enam universaalne standardlahendus, vaid valmib t\u00e4pse r\u00e4tsepat\u00f6\u00f6na iga patsiendi unikaalse bioloogia p\u00f5hjal. Esimest korda ajaloos on leitud tehnoloogia, mis suudab \u00f5petada inimese enda immuuns\u00fcsteemi \u00e4ra hoidma k\u00f5ige agressiivsema nahav\u00e4hi levikut ja tagasitulekut.<\/p>\n<p>Ravimifirmade Merck ja Moderna koost\u00f6\u00f6s arendatav eksperimentaalne mRNA-vaktsiin on n\u00e4idanud murrangulist v\u00f5imet peatada melanoomi taastekkimine.<\/p>\n","protected":false},"excerpt":{"rendered":"Meditsiin on astumas uude ajastusse, kus v\u00e4hiravi ei ole enam universaalne standardlahendus, vaid valmib t\u00e4pse r\u00e4tsepat\u00f6\u00f6na iga patsiendi&hellip;\n","protected":false},"author":2,"featured_media":258485,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[5],"tags":[26,27,37,33,35,34,36,31,32,21,79598,100637,100642,100639,23301,28,29,14886,100045,6820,100536,16297,34258,100638,19,100640,100643,25,100641,23,24,22,20,11708,30],"class_list":["post-258484","post","type-post","status-publish","format-standard","has-post-thumbnail","category-uldised-uudised","tag-breaking-news","tag-breakingnews","tag-ee","tag-eesti","tag-eesti-keel","tag-estonia","tag-estonian","tag-featured-news","tag-featurednews","tag-headlines","tag-immuunravi","tag-intismeran","tag-isiklik-vahivaktsiin","tag-keytruda","tag-kopsuvahk","tag-latest-news","tag-latestnews","tag-melanoom","tag-merck","tag-moderna","tag-mrna-vaktsiin","tag-nahavahk","tag-neeruvahk","tag-neoantigeen","tag-news","tag-personaalse-meditsiini","tag-poievahk","tag-populaarseimad-lood","tag-t-rakk","tag-top-stories","tag-topstories","tag-uldised-uudised","tag-uudised","tag-vahiravi","tag-viimased-uudised"],"share_on_mastodon":{"url":"","error":"Validation failed: Text character limit of 500 exceeded"},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ee\/wp-json\/wp\/v2\/posts\/258484","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ee\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ee\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ee\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ee\/wp-json\/wp\/v2\/comments?post=258484"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ee\/wp-json\/wp\/v2\/posts\/258484\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ee\/wp-json\/wp\/v2\/media\/258485"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ee\/wp-json\/wp\/v2\/media?parent=258484"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ee\/wp-json\/wp\/v2\/categories?post=258484"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ee\/wp-json\/wp\/v2\/tags?post=258484"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}